Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy Improves Survival with Acceptable Safety for Advanced Ovarian Cancer: A Clinical Study of 100 Patients

Table 5

Previously published studies for AOC patients with complete CRS in recent 5 years.

No.	Author	Year	No. (%)	mOS (mo)	mPFS (mo)	SAE (%)	Mortality (%)
1	Coccolini et al. [31]	2015	54 (100.0)	32.9	12.5	35.2	5.6
2	Kocic et al. [32]	2016	28 (96.8)	51.0	19.0	NA	NA
	Sun et al. [33]	2016	28 (60.9)	79.5	8.5	10.0	0.0
3	Manzanedo et al. [34]	2017	59 (97.0)	NA	17.0	NA	NA
4	Magge et al. [35]	2017	68 (90.6)	41.8	13.3	NA	NA
5	Pavlov et al. [2]	2017	112 (97.0)	40.3	26.7	9.5	0.8
6	Di Giorgio et al. [36]	2017	371 (72.6)	52.4	16.6	17.4	0.0
7	Mendivil et al. [24]	2017	68 (100.0)	33.8	25.1	0.0	0.0
8	Mercier et al. [16]	2018	155 (92.5)	69.3	30.3	NA	NA
9	van Driel et al. [10]	2018	106 (87.0)	45.7	14.2	27.0	0.0
10	This study	2019	79 (79.0)	95.2	67.8	4.0	2.0

NA: not available; mo: months.